By using an immunocapture-based assay, it was shown that patients with advanced melanoma patients (stage III and IV) had higher plasmatic exosomes levels as compared to healthy donors, with the best results with exosomes expressing caveolin-1 [16]. Here, CAV1 is linked to melanoma.